Clinical Biotechnology Research Institute at RSFH
Provide patients access to clinical research trials and cutting-edge technology.
IRS Tax Year 2024
Period ending December 31, 2024
Total Revenue
$585K
Total Expenses
$910K
Net Assets
$-26K
Employees
8
Volunteers
3
Program Expense Ratio
81.1%
This nonprofit profile presents IRS Form 990 tax filing data for Clinical Biotechnology Research Institute at RSFH (EIN: 47-5407453), based on the 2024 tax year annual return filed with the Internal Revenue Service.
Sections below include financial summaries (revenue, expenses, and net assets), program accomplishments, officer and key employee compensation, detailed executive pay breakdowns, governance policies and audit information, related tax-exempt organizations. All figures are reported in USD as filed.
Chat with Clinical Biotechnology Research Institute at RSFH's data & any nonprofit
Coming SoonCompare organizations, analyze trends, and ask questions about Clinical Biotechnology Research Institute at RSFH's finances, compensation, and programs — or any other nonprofit — using our AI-powered research assistant.
Financial Health
Transparency
Compensation
Program Effectiveness
Financial Stability
Risk Flags
Indicators derived from IRS Form 990 data. Not financial advice.
Clinical Biotechnology Research Institute at RSFH is a 501(c)(3) nonprofit headquartered in Ladson, SC, founded in 2015. It is classified under NTEE code H99 (Medical Research N.E.C.), within the Medical Research category. The organization has held tax-exempt status since 2017. In its 2024 filing, the organization reported $585K in total revenue, a 169.7% increase from the prior year, and $910K in total expenses. The organization employed 8 people and engaged 3 volunteers. Wael Haidar MD, Board Member, BSMH CHIEF CLINICAL OFFICER, is the highest-compensated individual at $2,539,165. The organization runs 1 program, totaling $738K in program expenses. 5 of 6 recommended governance policies are in place.
Clinical Biotechnology Research Institute at RSFH is classified under NTEE code H99 (Medical Research N.E.C.), which falls within the Medical Research category. Its foundation type is 12.
Programs(Tax Year 2024)
1 record
Clinical Biotechnology Research Institute at RSFH operates 1 program, with total program expenses of $738K. Clinical Biotechnology Research Institute at RSFH's largest program accounts for 100% of total program spending.
The CBRI is comprised of the Clinical Research Program and the Innovation Center. The robust research program allows patients access to the newest treatments and clinical trials available for varied conditions. It also creates an atmosphere of innovation, where we are building partnerships for the development of new therapies and establishing an intellectual research hub in the Lowcountry. The Innovation Center was created to turn biotechnology ideas into products/businesses by recruiting ideas from physicians and researchers all over the world. Ideas that are submitted will be evaluated by the Innovation Center team to determine feasibility and market potential. If the idea is selected, the team will put together a development plan.
Financial Overview(Tax Years 2019–2024)
6 records
Over the past 6 years, Clinical Biotechnology Research Institute at RSFH's revenue has declined from $3.2M to $585K, a 81.9% decrease. Program expenses represent 81% of total spending.
Revenue increased 169.7% year-over-year, while expenses declined 8.6%. net assets rose to $-26K, up 82.3% from the prior year. the organization reduced headcount by 6 employees.
Clinical Biotechnology Research Institute at RSFH derives 100% from program services.
Clinical Biotechnology Research Institute at RSFH allocates 81% to programs, 19% to management and general.
Revenue grew by 169.7% while expenses declined by only 8.6%, suggesting improving operational efficiency.
Over 6 filings from 2019–2024, Clinical Biotechnology Research Institute at RSFH declined revenue from $3.2M to $585K (-81.9%) while maintaining a program expense ratio of 81%. During this period, the organization reduced from 20 to 8 employees.
Clinical Biotechnology Research Institute at RSFH holds $84K in total assets against $109K in liabilities (debt-to-asset ratio of 130%). Cash and equivalents of $0 cover approximately 0.0 months of expenses.
Revenue
| Year | Total Revenue | Contributions | Gov't Grants | Program Revenue | Investment |
|---|---|---|---|---|---|
| 2024 | $585K | $0 | $0 | $585K | $0 |
| 2023 | $217K | $25K | $0 | $192K | $0 |
| 2022 | $256K | $81K | $0 | $176K | $0 |
| 2021 | $844K | $0 | $0 | $821K | $-66 |
| 2020 | $2.6M | $679K | $298K | $1.9M | $0 |
| 2019 | $3.2M | $889K | $477K | $2.3M | $0 |
Expenses
| Year | Total Expenses | Program | Management | Fundraising | Grants Paid |
|---|---|---|---|---|---|
| 2024 | $910K | $738K | $172K | $0 | $0 |
| 2023 | $996K | $817K | $178K | $0 | $0 |
| 2022 | $746K | $600K | $146K | $0 | $0 |
| 2021 | $2.0M | $1.5M | $446K | $0 | $250 |
| 2020 | $3.3M | $2.6M | $708K | $0 | $296K |
| 2019 | $3.1M | $2.4M | $751K | $0 | $0 |
Program Expense Ratio
81.1%
Admin Expense Ratio
18.9%
Fundraising Efficiency
—
Operating Reserve
-0.3 mo
People & Compensation(Tax Year 2024)
23 records
Clinical Biotechnology Research Institute at RSFH reported compensation for 23 officers and key employees. Total officer compensation was $17.3M, representing 1902.6% of total expenses. 14 individuals received total compensation exceeding $500,000.
Clinical Biotechnology Research Institute at RSFH's highest-compensated individual received $2.5M in total compensation. Total officer compensation of $17.3M represents 1902.6% of total expenses. 7 individuals received total compensation exceeding $1,000,000.
| Name | Title | Type | Hours/wk | Comp from Org | Related Orgs | Total |
|---|---|---|---|---|---|---|
| Wael Haidar MD | Board Member, BSMH CHIEF CLINICAL OFFICER | Director | 0.50 | $0 | $1,988,113 | $2,539,165 |
| Jeffrey DiLisi | Former President/CEO RSFH | Former | — | $0 | $2,056,692 | $2,068,411 |
| JOSEPH GAGE JR JD | Board Member, BSMH Chief HR Officer | Director | 0.50 | $0 | $1,480,052 | $1,778,346 |
| Michael Lutes | Board Member, Richmond Market President - BSMH | Director | 0.50 | $0 | $1,113,136 | $1,433,183 |
| Scott Woodfield MD | Board Vice Chair, RSFPP Physician | OfficerDirector | 0.50 | $0 | $1,167,520 | $1,223,580 |
| Brian Cuddy MD | Former Chairperson, Neurosurgeon - RSFPP | Former | — | $0 | $1,129,716 | $1,185,598 |
| Eric Smith | Board Member, CFO Ambulatory Finance - BSMH | Director | 0.50 | $0 | $854,751 | $1,011,638 |
| Megan Baker MD | Board Member; Interim President RSF Foundation | OfficerDirector | 0.50 | $0 | $901,811 | $980,327 |
| John Spratt MD | Board Member, Physician | Director | 0.50 | $0 | $891,404 | $950,812 |
| Brian Yanofchick | Board Member, Chief Sponsorship Officer-BSMH | Director | 0.50 | $0 | $716,610 | $739,855 |
| Cheryl Dalton-Norman | Board Member, President - Conduit Health Partners | Director | 0.50 | $0 | $580,510 | $620,247 |
| Joseph DeLeon | President/CEO RSFH | Officer | 0.50 | $0 | $532,392 | $602,447 |
| Henry West MD | Board Member, Surgeon - RSFPP | Director | 0.50 | $0 | $548,163 | $590,653 |
| Brad Grosteffon | Interim CFO/Treasurer | Officer | 0.50 | $0 | $519,231 | $584,779 |
| Susan Datta MD | Board Member, Internist - RSFPP | Director | 0.50 | $0 | $415,338 | $432,813 |
| Rebecca Tucker | CFO/Treasurer | Officer | 0.50 | $0 | $234,228 | $262,074 |
| Bree Maddray | Lead RN Clinical Research | Highest Comp | 40.00 | $139,476 | $0 | $182,705 |
| Julia Johnson | Research Manager | Highest Comp | 40.00 | $108,644 | $0 | $131,168 |
| Kay W Phillips PhD | Board Member | Director | 0.50 | $0 | $0 | $0 |
| Karen Wrighten | Board Member | Director | 0.50 | $0 | $0 | $0 |
| Charles Ford Rivers III | Board Member | Director | 0.50 | $0 | $0 | $0 |
| Edward McKelvey | Board Chair | OfficerDirector | 0.50 | $0 | $0 | $0 |
| Roberta Pinckney | Board Member | Director | 0.50 | $0 | $0 | $0 |
Compensation Breakdown
Schedule J detail — base, bonus, benefits, and executive perks
Wael Haidar MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
JOSEPH GAGE JR JD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Eric Smith
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Michael Lutes
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Brian Yanofchick
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Jeffrey DiLisi
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Brian Cuddy MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Joseph DeLeon
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Rebecca Tucker
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Brad Grosteffon
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Megan Baker MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Scott Woodfield MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
John Spratt MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Susan Datta MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Henry West MD
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Cheryl Dalton-Norman
Base Salary
—
Bonus
—
Other Reportable
—
Retirement/Deferred
—
Nontaxable Benefits
—
Bree Maddray
Base Salary
$115,274
Bonus
$1,347
Other Reportable
$22,855
Retirement/Deferred
$6,715
Nontaxable Benefits
$36,514
Governance & Compliance(Tax Year 2024)
Clinical Biotechnology Research Institute at RSFH has 5 of 6 recommended governance policies in place, including conflict of interest, whistleblower, document retention. Its board has 13 members, 3 of whom are independent.
Clinical Biotechnology Research Institute at RSFH's financial statements are audited, an audit committee oversees the process.
Policies & Oversight
Audit & Financial Oversight
Filing History(Tax Years 2017–2024)
6 records
Showing the 6 Form 990 filings currently in our system.
| Tax Year | Form | Period | Revenue | Expenses | Net Assets |
|---|---|---|---|---|---|
| 2024 | 990 | 2024-01-01 – 2024-12-31 | $585K | $910K | $-26K |
| 2023 | 990 | 2023-01-01 – 2023-12-31 | $217K | $996K | $-144K |
| 2022 | 990 | 2022-01-01 – 2022-12-31 | $256K | $746K | $-2.5M |
| 2021 | 990 | 2021-01-01 – 2021-12-31 | $844K | $2.0M | $-2.0M |
| 2020 | 990 | 2020-01-01 – 2020-12-31 | $2.6M | $3.3M | $-769K |
| 2019 | 990 | 2019-01-01 – 2019-12-31 | $3.2M | $3.1M | $105K |
| 2017–2018 | No filings acquired yet | ||||
Frequently Asked Questions
What does Clinical Biotechnology Research Institute at RSFH do?
Provide patients access to clinical research trials and cutting-edge technology.
How much revenue does Clinical Biotechnology Research Institute at RSFH have?
Clinical Biotechnology Research Institute at RSFH reported $585,349 in total revenue for tax year 2024, up 169.7% from the prior year.
Who is the highest-paid executive at Clinical Biotechnology Research Institute at RSFH?
Wael Haidar MD, Board Member, BSMH CHIEF CLINICAL OFFICER, received $2,539,165 in total compensation as of tax year 2024.
Is Clinical Biotechnology Research Institute at RSFH a 501(c)(3)?
Yes, Clinical Biotechnology Research Institute at RSFH is classified as a 501(c)(3) tax-exempt organization.
Where is Clinical Biotechnology Research Institute at RSFH located?
Clinical Biotechnology Research Institute at RSFH is headquartered in Ladson, SC 29456.
How many employees does Clinical Biotechnology Research Institute at RSFH have?
Clinical Biotechnology Research Institute at RSFH has 8 employees and 3 volunteers as of tax year 2024.
What type of nonprofit is Clinical Biotechnology Research Institute at RSFH?
Clinical Biotechnology Research Institute at RSFH is classified under NTEE code H99 (Medical Research N.E.C.), within the Medical Research category. It is a 501(c)(3) tax-exempt organization.
Is Clinical Biotechnology Research Institute at RSFH audited?
Yes, Clinical Biotechnology Research Institute at RSFH's financial statements are audited, and the organization has an audit committee.
Data Source
IRS Form 990 electronic filings via the IRS Exempt Organizations Business Master File. All financial figures are as reported in USD.
Ask anything about
any nonprofit
Get instant, data-backed answers about nonprofit compensation, financials, and trends. Join the waitlist for early access. Free tier included at launch.
Trusted by nonprofit professionals
3.6M+
IRS Filings
1.7M+
Organizations
28M+
Comp Records